Fast Medtech Recovery Doubted by Goldman, JPMorgan Analysts

June 1, 2020, 4:32 PM

Two Wall Street analysts issued a warning on the pace of recovery for medical technology stocks as states slowly begin to reopen and elective surgeries are resumed.

Operating rooms won’t reach 100% of pre-pandemic capacity until the second half of next year, Goldman analysts warned, pushing out their prior estimates for a full recovery by the first half of 2021.

“The average age for patients undergoing surgeries in the U.S. is in the early 70s, among the highest-risk category for Covid,” and those elderly patients in particular are more likely to defer procedures until after a vaccine is available, Goldman ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.